Publications by authors named "Xue Qing D Wang"

Claim this Profile
S
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer.
Yibo Xue, Brian Meehan, Zheng Fu, Xue Qing D Wang, Pierre Olivier Fiset

Nat Commun· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary.
Yibo Xue, Brian Meehan, Elizabeth Macdonald, Sriram Venneti, Xue Qing D Wang

Nat Commun· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis